TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
NAUT

Nautilus Biotechnology Inc

Healthcare · Biotechnology

1.10$ +15.3% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Nautilus Biotechnology Inc (NAUT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 53.0% of the shares are freely tradable; institutional investors hold 42.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 42.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 32.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 53.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 6.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 127Mio.

Largest Shareholders

Institutions

Institutions NAUT
Name Stake (%) Shares Change (%) Date
Perceptive Advisors LLC 9.14 11,634,211 -7.6 06/30/2026
Cercano Management LLC 5.64 7,172,985 +0.0 03/31/2026
Vanguard Capital Management, LLC 2.00 2,545,597 +0.0 03/31/2026
Hartland & Co 1.83 2,329,784 +0.0 03/31/2026
Comprehensive Financial Management LLC 1.73 2,207,619 +0.0 06/30/2026
Citadel Advisors Llc 1.49 1,896,192 +0.0 06/30/2026
Sentinel Trust CO Lba 0.59 750,000 +0.0 06/30/2026
Acadian Asset Management LLC 0.58 741,246 +0.0 03/31/2026

Funds

Funds NAUT
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.52 1,930,610 +0.0 08/31/2026
iShares Russell 2000 ETF 0.83 1,056,756 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?